Glad we agree for once. B-absssi results were comparable to Dapto - I’d say 2 gold increase for success B-OM - currently zero preventative drugs on market - results were outstanding considering the placebo rate of OM was only 60% which is historically about 10-20% lower than normal. Add the historic rates and the trial results just became SUPER!!!
Prurisol TBD in the next 5 weeks. Anything above 25% PASI 75 would be ideal if safety trumps Otezla and it may work faster....
I’d say we have 3 really good chances of two fold increase to market.